ClinConnect ClinConnect Logo
Search / Trial NCT07061223

Trial Information

Current as of July 24, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

Patients will be randomized into three groups group:

Group 1: General anesthesia with SFIB

In this group, under the ultrasound control, a local anesthetic will be injected into the interfacial space of the iliac muscle, in the area of the passage of the deep artery that surrounds the ilium. The block will be performed over the inguinal fold medial to the upper anterior iliac spine. After ultrasound identification of the needle's location in the interfacial space, 40 ml of a 0.5% solution of Ropivacaine will be administered.

Group 2: General anesthesia with PENG block

The block is perfor...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Signed, dated informed consent form
  • Age from 50 to 75 years
  • Indications for primary total hip replacement
  • American Society of Anesthesiologists (ASA) score from 1 to 3
  • Exclusion Criteria:
  • Patients receiving beta blockers;
  • Infectious manifestations at the puncture site;
  • Bleeding, clinically significant hypovolemia of any origin, shock;
  • Disorders of the blood coagulation system;
  • Intolerance to local anesthetics;
  • Demyelinating diseases of the nervous system;
  • Allergy to local anesthetics;
  • Psychiatric diseases;
  • Any conditions that prevent obtaining informed consent.

About State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry Of Health Of Russia

The National Medical Surgical Center named after N.I. Pirogov, a state budgetary healthcare institution under the Ministry of Health of Russia, is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes. With a strong emphasis on innovative surgical techniques and comprehensive healthcare solutions, the center operates at the forefront of clinical trials, facilitating the development and evaluation of new therapies and medical devices. Leveraging its state-of-the-art facilities and a team of expert clinicians, the institution fosters collaboration with national and international research entities to enhance the efficacy and safety of medical interventions, ultimately contributing to the advancement of public health in Russia and beyond.

Locations

Moscow, , Russian Federation

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported